Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application

Kenneth C Anderson

Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Conor C Lynch

Specific skeletal targeting of MMP-2 for the treatment of multiple myeloma

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Irene M. Ghobrial

Stroma-mediated clonal evolution in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Charles Rabkin

BCL2 Translocations in Healthy Individuals

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Robert L Comis

ECOG-ACRIN Operations Center

Trachea, bronchus and lung Prostate Pancreas Non-Hodgkin lymphoma Nasopharynx Multiple myeloma and immunoproliferative diseases Melanoma of skin Leukaemia Colorectum Breast Bladder

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies Pathology

Catriona HM Jamieson

(PQC2) Niche-responsive RNA editing by ADAR1 in dormant multiple myeloma initiating cell maintenance

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Tracy L Mcgaha

The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

David L Woodland

Immune Evolution in Cancer

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology